Core Viewpoint - Leidos Holdings, Inc. reported strong financial performance in Q1 2025, with adjusted earnings per share significantly exceeding expectations and showing substantial year-over-year growth [1][2]. Financial Performance - Adjusted earnings per share for Q1 2025 were $2.97, surpassing the Zacks Consensus Estimate of $2.47 by 20.2% and increasing 29.7% from $2.29 in the prior-year quarter [1] - GAAP earnings were $2.77 per share, up from $2.07 in the same quarter last year [1] - Total revenues reached $4.25 billion, exceeding the Zacks Consensus Estimate of $4.08 billion by 4% and reflecting a 6.8% year-over-year increase [3] Operational Statistics - Cost of revenues increased by 4.5% year over year to $3.49 billion [5] - Adjusted operating income rose to $565 million from $456 million in the previous year [5] - Adjusted operating margin improved to 13.3% compared to 11.5% in the prior-year period [5] Backlog and Segment Performance - Total backlog increased to $46.30 billion from $43.56 billion at the end of Q4 2024, with $7.33 billion funded [4] - National Security and Digital segment revenues grew 4.7% year over year to $1.88 billion, while adjusted operating income slightly declined to $190 million [6] - Health & Civil segment revenues rose 7.7% to $1.29 billion, with adjusted operating income increasing to $305 million [7] - Commercial & International segment revenues reached $568 million, up 11.6% year over year, with adjusted operating income at $48 million [8] - Defense Systems segment revenues were $508 million, up 7.2%, with adjusted operating income increasing to $46 million [10] Financial Position - Cash and cash equivalents totaled $842 million, a slight decrease from $849 million at the beginning of the year [11] - Long-term debt increased to $5.01 billion from $4.05 billion [11] - Net cash flow from operating activities was $58 million, down from $113 million a year ago [11] 2025 Guidance - Leidos reaffirmed its 2025 guidance, expecting adjusted earnings in the range of $10.35-$10.75 per share, with the Zacks Consensus Estimate at $10.51 [12] - The company anticipates revenues between $16.90-$17.30 billion, with the Zacks Consensus Estimate at $17.09 billion [12] - Expected cash flow from operating activities for 2025 is approximately $1.45 billion [13]

Financial Performance - Leidos reported revenues of $4,245 million for the three months ended April 4, 2025, representing a 6.8% increase from $3,975 million for the same period in 2024[93]. - Operating income increased by 27.7% to $530 million for the three months ended April 4, 2025, compared to $415 million for the same period in 2024[93]. - Net income attributable to Leidos common stockholders was $363 million, a 27.8% increase from $284 million in the prior year[93]. - The Health & Civil segment saw a revenue increase of 7.7% to $1,291 million, with operating income rising by 34.7% to $299 million[96]. - The Defense Systems segment reported revenues of $508 million, a 7.2% increase, with operating income up 61.9% to $34 million[98]. - Revenues for the three months ended April 4, 2025, were $2,698 million, with an operating income of $235 million and a net income attributable to common stockholders of $32 million[126]. Government Contracts - The company generated approximately 87% of total revenues from U.S. government contracts, indicating a strong reliance on government spending[88]. Bookings and Backlog - Net bookings for the three months ended April 4, 2025, were estimated at $2.1 billion, down from $3.8 billion in the same period in 2024[106]. - Total backlog as of April 4, 2025, was $46,296 million, which includes $7,329 million in funded backlog[106]. Cash Flow and Liquidity - During the three months ended April 4, 2025, net cash provided by operating activities was $58 million, a decrease of $55 million compared to $113 million in the prior year quarter[117]. - Net cash used in investing activities increased by $10 million to $22 million for the three months ended April 4, 2025, primarily due to higher capital expenditures of $5 million[118]. - Net cash used in financing activities decreased by $118 million to $110 million for the three months ended April 4, 2025, mainly due to a net increase of $465 million in cash inflows from debt issuance[119]. - The company anticipates meeting liquidity needs for the next 12 months through cash generated from operations and available cash balances[116]. Debt and Liabilities - As of April 4, 2025, Leidos had $842 million in cash and cash equivalents and outstanding debt of $5.1 billion[108][109]. - Long-term debt, net of current portion, increased to $5,014 million as of April 4, 2025, compared to $4,052 million on January 3, 2025[125]. - Total liabilities increased to $11,416 million as of April 4, 2025, from $10,868 million on January 3, 2025[125]. Tax and Market Risk - The effective tax rate for the three months ended April 4, 2025, was 23.6%, an increase from 23.1% in the prior year[103]. - There were no material changes in market risk exposure compared to the previous annual report[131]. Stock Repurchase - The company made open market repurchases of common stock totaling $150 million during the three months ended March 29, 2024[115].

Leidos (LDOS) reported $4.25 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 6.8%. EPS of $2.97 for the same period compares to $2.29 a year ago.The reported revenue represents a surprise of +4.03% over the Zacks Consensus Estimate of $4.08 billion. With the consensus EPS estimate being $2.47, the EPS surprise was +20.24%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expec ...

Leidos (LDOS) came out with quarterly earnings of $2.97 per share, beating the Zacks Consensus Estimate of $2.47 per share. This compares to earnings of $2.29 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 20.24%. A quarter ago, it was expected that this security and engineering company would post earnings of $2.18 per share when it actually produced earnings of $2.37, delivering a surprise of 8.72%.Over the last four quarter ...

Leidos (LDOS) Q1 2025 Earnings Call May 06, 2025 08:00 AM ET Speaker0 Greetings. Welcome to Leidos First Quarter twenty twenty five Earnings Conference Call. At this time, all participants are in a listen only mode. A brief question and answer session will follow the formal presentation. Please note this conference is being recorded. At this time, I'll turn the conference over to Stuart Davis from Investor Relations. Stuart, you may begin. Speaker1 Thank you, and good morning, everyone. I'd like to welcome ...

Leidos (LDOS) Q1 2025 Earnings Call May 06, 2025 08:00 AM ET Company Participants Stuart Davis - Senior Vice President, Investor RelationsThomas Bell - CEOChris Cage - Executive VP & CFOJoshua Korn - Assistant VP, Equity ResearchSheila Kahyaoglu - Aerospace & Defense and Airlines Equity ResearchColin Canfield - DirectorMariana Pérez Mora - DirectorJason Gursky - Managing DirectorTyler Barishaw - Equity Research AssociateScott Mikus - Director – Aerospace, Defense & Space ResearchKen Herbert - Managing Direc ...

Leidos Q1 FY25 Earnings Conference Call MAY 6, 2025 FORWARD-LOOKING STATEMENTS Certain statements in this release contain or are based on "forward- looking" information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as "expects," "intends," "plans," "anticipates," "believes," "estimates," "guidance" and similar words or phrases. Forward-looking statements in this release include, among others, estimates of ...

SUMMARY OPERATING RESULTS | | | | Three Months Ended | | | --- | --- | --- | --- | --- | | (in millions, except margin and per share data) | | April 4, 2025 | | March 29, 2024 | | Revenues | $ | 4,245 | $ | 3,975 | | Net income | $ | 365 | $ | 283 | | Net income margin | | 8.6 % | | 7.1 % | | Diluted earnings per share (EPS) | $ | 2.77 | $ | 2.07 | | Non-GAAP Measures*: | | | | | | Adjusted EBITDA | $ | 601 | $ | 490 | | Adjusted EBITDA margin | | 14.2 % | | 12.3 % | | Non-GAAP diluted EPS | $ | 2.97 | $ | ...

RESTON, Va., May 5, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) will modernize and operate information technology systems for the Defense Threat Reduction Agency (DTRA) enterprise that will help the agency deter, prevent and prevail against emerging threats around the world.  As part of this IT transformation, Leidos will support DTRA's advance toward a Zero Trust cybersecurity posture.Through a recently awarded $205 million contract, Leidos will use artificial intelligence technologies to accelerate DTRA's pro ...

RESTON, Va., April 18, 2025 /PRNewswire/ -- Leidos (NYSE: LDOS) is committing $10 million to accelerate the use of artificial intelligence for detecting and managing diseases, in collaboration with the University of Pittsburgh's Computational Pathology and AI Center of Excellence (CPACE).The initial focus of the five-year collaboration will be developing AI-powered tools for quicker detection of diseases, such as heart disease and cancer, reducing diagnostic turnaround times, and enabling earlier, more effe ...